MAIORE, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.014
AS - Asia 1.553
SA - Sud America 1.064
EU - Europa 1.055
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 34
OC - Oceania 1
Totale 6.801
Nazione #
US - Stati Uniti d'America 2.938
BR - Brasile 954
SG - Singapore 596
CN - Cina 518
UA - Ucraina 367
IT - Italia 232
VN - Vietnam 154
DE - Germania 136
HK - Hong Kong 81
FR - Francia 68
FI - Finlandia 59
GB - Regno Unito 56
SE - Svezia 56
AR - Argentina 50
ZA - Sudafrica 29
CA - Canada 27
BD - Bangladesh 24
MX - Messico 24
TR - Turchia 24
IN - India 23
IQ - Iraq 21
RU - Federazione Russa 20
UZ - Uzbekistan 16
BE - Belgio 15
EC - Ecuador 14
ID - Indonesia 13
JP - Giappone 13
CO - Colombia 12
MA - Marocco 11
PK - Pakistan 11
TN - Tunisia 11
ES - Italia 9
KE - Kenya 9
PY - Paraguay 9
KZ - Kazakistan 8
NL - Olanda 8
EG - Egitto 7
VE - Venezuela 7
CL - Cile 6
IR - Iran 6
JO - Giordania 6
UY - Uruguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
NI - Nicaragua 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
PE - Perù 4
CR - Costa Rica 3
EU - Europa 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
LB - Libano 3
SA - Arabia Saudita 3
SN - Senegal 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
EE - Estonia 2
HU - Ungheria 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
AO - Angola 1
AT - Austria 1
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
IE - Irlanda 1
KG - Kirghizistan 1
KH - Cambogia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 6.775
Città #
Dallas 723
Singapore 293
Chandler 273
Jacksonville 219
San Jose 218
Ashburn 194
Beijing 115
Princeton 111
Council Bluffs 101
Santa Clara 89
Dearborn 78
Hong Kong 78
Nanjing 73
São Paulo 69
Columbus 66
Sassari 62
Ann Arbor 58
Ho Chi Minh City 54
Lauterbourg 49
Wilmington 49
Hanoi 37
Los Angeles 36
Nanchang 35
Rio de Janeiro 30
Milan 29
Washington 28
Belo Horizonte 26
Brasília 26
Shanghai 25
Tianjin 24
Hebei 23
Changsha 21
Shenyang 21
Mountain View 20
Jiaxing 18
Woodbridge 17
Boardman 16
Brussels 15
New York 15
San Francisco 15
Toronto 15
Jinan 14
Porto Alegre 14
Tashkent 14
Johannesburg 13
Rome 13
The Dalles 13
Tokyo 13
Curitiba 12
Salvador 12
San Mateo 12
Zhengzhou 12
Bologna 11
Buenos Aires 11
Florence 11
Leawood 11
Baghdad 10
Ankara 9
Chicago 9
Hangzhou 9
Ningbo 9
Ribeirão Preto 9
Cagliari 8
Can Tho 8
Goiânia 8
Haiphong 8
Kunming 8
Miano 8
Atlanta 7
Brooklyn 7
Campinas 7
Cape Town 7
Caxias do Sul 7
Da Nang 7
Dhaka 7
Juazeiro do Norte 7
Maceió 7
Monmouth Junction 7
Nairobi 7
Perugia 7
Santo André 7
São Luís 7
Viamão 7
Vila Velha 7
Amman 6
Buffalo 6
Campo Grande 6
Florianópolis 6
Fortaleza 6
Frankfurt am Main 6
Guarulhos 6
Helsinki 6
Juiz de Fora 6
Montevideo 6
Nova Iguaçu 6
Orem 6
Sorocaba 6
São Bernardo do Campo 6
Augusta 5
Baku 5
Totale 3.959
Nome #
[Au2(phen2Me)2(?-O)2](PF6)2, a novel dinuclear gold(III) complex showing excellent antiproliferative properties 209
Catalytic and Biological studies of Au(III) complexes with pyridinyl-oxazoline ligands 194
Gold(III) Adducts with Chiral Pyridinyl-Oxazolines. Synthesis, Reactivity of the Coordinated Ligands and Structural Characterizations 188
[Au(pyb-H)(mnt)]: A novel gold(III) 1,2-dithiolene cyclometalated complex with antimicrobial activity (pyb-H = C-deprotonated 2-benzylpyridine; mnt = 1,2-dicyanoethene-1,2-dithiolate) 177
New Variations on the Theme of Gold(III) C ∧ N ∧ N Cyclometalated Complexes as Anticancer Agents: Synthesis and Biological Characterization 172
Gold(III) Complexes with 2-Substituted Pyridines as Experimental Anticancer Agents: Solution Behaviour, Reaction with Model Proteins, Antiproliferative Properties. 171
Complessi mono e dinucleari di oro (i) e oro (iii): applicazioni in campo farmacologico e catalitico 165
Cytotoxic Properties of a New Organometallic Platinum(II) Complex and its Gold(I) Heterobimetallic Derivatives 165
Caged noble metals: Encapsulation of a cytotoxic platinum(II)-gold(I) compound within the ferritin nanocage 164
Synthesis, Solution Behavior, Molecular and Supramolecular Structures of the Water- soluble Gold(I) Saccharinate Complexes M[Au(Sac)2] (M = Na, K, NH4) 158
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 155
Gold(III) derivatives with a-diimines as potential antitumor agents: synthesis and characterization 152
A Gold(III) Push-Pull Mixed-Ligand Complex for ICT Applications: Synthesis, Characterization, and DFT Investigation 152
Complessi mono- ed eterodinucleari di oro, platino e palladio: sintesi e caratterizzazione 150
Biological studies on a new class of gold complexes with pyridinyl-benzoimidazole 148
Synthesis, structural characterization and in vitro cytotoxicity of gold complexes with 2-(2-pyridyl)benzimidazole. Gold)III) vs. cold(I), mono- vs. binuclear derivatives 142
Biological studies on a new class of gold complexes with pyridinyl-benzoimidazole 137
Gold(III) Complexes with 2-Substituted Pyridines as Experimental Anticancer Agents: Solution Behaviour, Reactions with Model Proteins, Antiproliferative Properties 136
Synthesis, characterization and evaluation of gold complexes as anti microbial compounds 131
Gold saccharinato derivatives as potential antimalarial agents 126
Design, synthesis, and quantum-mechanical modeling of inorganic salts as protection and consolidation agents of stone substrates 125
Gold(III) derivatives with α-diimines as potential antitumor agents: synthesis and characterisation 124
Synthesis, characterization and DFT-modeling of novel agents for the protection and restoration of hystorical calcareous stone substrates 119
Synthesis, structural characterization and in vitro cytotoxicity of gold complexes with 2-(2-pyridyl)benzimidazole. Gold(III) vs. Gold(I), mononuclear vs. binuclear derivatives 118
Ferritin nanocages loaded with gold ions induce oxidative stress and apoptosis in MCF-7 human breast cancer cells 118
Synthesis, Solution Behavior, Molecular and Supremolecular Structures of the Water-soluble Gold(I) Saccharinate Complexes M[Au(Sac)2] (M = Na, K, NH4) 117
Intramolecular C(sp2)-H Bond Activation in 6,6'-Dimethoxy-2,2'-Bipyridine with Gold(III). Crystal and Molecular Structure of the First N',C(3) “Rollover” Cycloaurated Derivative 114
Synthesis and reactivity of gold(III) C^N^N cyclometalated derivatives 113
Sintesi e studio della reattività di complessi di Au con proprietà citotossiche 111
Gold complexes as potential antimalarial agents 111
Selected Cytotoxic Gold Compounds cause Significant Inhibition of 20S Proteasome Catalytic Activities 108
Mono- and dinuclear gold(I/III) complexes of 2-pyridyl(2-benzimidazole):synthesis, structure and catalysis in A3-reaction of aldehydes, amines, and alkynes in water 107
Gold complexes as antimicrobial agents 104
Proprietà antimalariche del complessi di oro 103
Oxamate salts as novel agents for the restoration of marble and limestone substrates: Case study of ammonium N-phenyloxamate 103
Structural and solution chemistry, protein binding and antiproliferative profiles of gold (I)/(III) complexes bearing the saccharinato ligand 100
Synthesis of the first Pd(II), Pt(II) and Au(III) derivatives with 6,6’-dimethoxy-2,2’-bipyridine 100
Metal-Based Compounds as Prospective Antileishmanial Agents: Inhibition of Trypanothione Reductase by Selected Gold Complexes. 99
Structural, theoretical and spectroscopic characterisation of a series of novel gold(I)-norbornene complexes supported by phenanthrolines: effects of the supporting ligand 96
Nuovi complessi di Au(I) ed Au(III) con leganti biocompatibili e solubili in H2O: sintesi, caratterizzazione e studio dell’attività biologica 95
Pd(II), Pt(II) and Au(III) adducts and cyclometalated derivatives with 6,6’-dimethoxy-2,2’-bipyridine 94
Mono- and dinuclear gold(I/III) complexes of 2-pyridyl(2-benzimidazole):synthesis, structure and catalysis in A3-reaction of aldehydes, amines, and alkynes in water 93
Synthesis and structural characterization of new mono and dinuclear gold(I) complexes as potential antitumor agents 89
Novel gold(I)/gold(III) compounds bearing saccharinate ligands: structural and solution chemistry, protein binding behaviour and antiproliferative effects 87
New gold(III) complexes with chiral 2-pyridinil-2.oxazoline: Synthesis, Reactivity and Structures 86
Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme 85
New Gold Complexes with Nitrogen Ligands: Synthesis, Reactivity and Structures 84
New gold(III) complexes with chiral α-diiminic ligands: Synthesis, Reactivity and Structures 84
Nuovi complessi di oro(i,iii) con proprietà antiplasmodiche 84
Structure-activity relationships in cytotoxic AuI/Au III complexes derived from 2-(2′-pyridyl)benzimidazole 83
Synthesis and Characterization of Novel Inorganic Salts as Protection and Consolidation Agents of Stone Substrates: an Experimental and Theoretical Study 82
Mono- and Binuclear Gold Based Complexes with Anti-tumoral Properties 81
Selected gold compounds cause pronounced inhibition of Falcipain 2 and effectively block P. falciparum growth in vitro 80
Synthesis and reactivity of gold(III) cyclometalated derivatives with C^N^N donor ligands 78
Sintesi e sviluppo di complessi di oro con potenziali applicazioni in campo farmacologico e nella catalisi 78
New gold(III) complexes with chiralα-diiminic ligands: Stnthesis, reactivity and Structures 71
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives 59
null 26
Totale 6.801
Categoria #
all - tutte 27.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022226 0 0 0 2 3 1 7 29 24 13 26 121
2022/2023494 61 47 1 88 52 74 1 56 71 3 25 15
2023/2024133 25 11 1 7 32 0 0 7 0 0 17 33
2024/20251.576 5 9 74 29 55 34 77 312 610 270 56 45
2025/20262.276 90 581 352 438 126 101 316 61 59 100 43 9
2026/2027684 34 166 189 295 0 0 0 0 0 0 0 0
Totale 6.801